The company in question is, Bio-Techne Corp. (NASDAQ:TECH) currently with a stock price of 106.23 (0.50% today). The market cap for Bio-Techne Corp. is 3950.01, and is in the sector Healthcare, and Biotechnology industry. The target price for Bio-Techne Corp. is 116. Currently Bio-Techne Corp. is trading with a P/E of 37.76, and a forward P/E of 26.49. Average volume for Bio-Techne Corp. is 174.06 and so far today it is 41380.
Performance in the last year for Bio-Techne Corp. has been 17.01%. For EPS growth, Bio-Techne Corp. has seen a growth of -3.30%, and is looking to grow in the next year to 9.62%. More long term stats show that EPS growth has been -1.50% over the last five years and could be 12.50% for the next five years. Bio-Techne Corp. has seen sales growth quarter over quarter at 14.50%, with EPS growth quarter over quarter at -2.90%. The 20-day simple moving average is -2.06%, with the 200-day simple moving average coming to 5.90%.
Since the IPO date for Bio-Techne Corp. on the 12/09/1992, Bio-Techne Corp. has seen performance year to date to be 18.62%. With Bio-Techne Corp. trading at 106.23, the dividend yield is 1.21%, and the EPS is 2.8.
So could Bio-Techne Corp., be undervalued? Well as said before P/E is 37.76. The PEG is 3.02, P/S is 7.92 and the P/B is at 4.48. The P/cash is 41.23, with P/free cash flow at 49.75.
Bio-Techne Corp. ability to deal with debt shows that the current ratio is 4.7, and the quick ratio is 3.6. This is with long term debt/equity at 0.1, and total debt/equity at 0.11.
In terms of margins, Bio-Techne Corp. has a gross margin of 67.50%, an operating margin of 30.20% and a profit margin of 20.90%.Payout ratio for Bio-Techne Corp. is 45.60%. Return on assets come to 9.30% with return on investment coming to 11.00%.
Insider ownership for Bio-Techne Corp., is at 0.20% and institutional ownership comes to 100.00%. Outstanding shares are at 37.37. While shares float is 37.17. The float short is currently 4.08%, and short ratio is 8.72.